Unveiling vaccine safety: a narrative review of pharmacovigilance in India's COVID-19 vaccination
In India, a robust vaccine pharmacovigilance system is essential to the effective implementation of COVID-19 immunization programs, ensuring the safety and efficacy of the administered vaccines. The National Expert Group on Vaccine Administration for COVID-19 and the Pharmacovigilance Programme of...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2023-12-01
|
| Series: | Monaldi Archives for Chest Disease |
| Subjects: | |
| Online Access: | https://www.monaldi-archives.org/index.php/macd/article/view/2793 |
| _version_ | 1827619859033227264 |
|---|---|
| author | Megha Hegde Saurav Raj Dhananjay Tikadar Sanatkumar B Nyamagoud |
| author_facet | Megha Hegde Saurav Raj Dhananjay Tikadar Sanatkumar B Nyamagoud |
| author_sort | Megha Hegde |
| collection | DOAJ |
| description |
In India, a robust vaccine pharmacovigilance system is essential to the effective implementation of COVID-19 immunization programs, ensuring the safety and efficacy of the administered vaccines. The National Expert Group on Vaccine Administration for COVID-19 and the Pharmacovigilance Programme of India have played vital roles in monitoring and analyzing adverse events following immunization (AEFI). These tools have made it easier to gather, assess, and report information about different adverse drug reactions connected to COVID-19 vaccines. However, there are several issues with India's vaccination pharmacovigilance, including underreporting and sluggish data gathering. To improve the efficiency of the pharmacovigilance system, it is crucial to address these issues and encourage active reporting by healthcare professionals and the general public. This insightful review article serves as a critical resource for shedding light on India's vaccine pharmacovigilance efforts throughout the COVID-19 vaccination drive. It also elucidates how these efforts are pivotal in bolstering public confidence in vaccines. The comprehensive coverage of reported AEFI not only showcases the commitment to vaccine safety but also helps healthcare professionals and policymakers make informed decisions to enhance the overall vaccination program.
|
| first_indexed | 2024-03-09T10:38:36Z |
| format | Article |
| id | doaj.art-52b20eeb2ef44d3f8195aed7b9daef96 |
| institution | Directory Open Access Journal |
| issn | 1122-0643 2532-5264 |
| language | English |
| last_indexed | 2024-03-09T10:38:36Z |
| publishDate | 2023-12-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Monaldi Archives for Chest Disease |
| spelling | doaj.art-52b20eeb2ef44d3f8195aed7b9daef962023-12-01T19:10:52ZengPAGEPress PublicationsMonaldi Archives for Chest Disease1122-06432532-52642023-12-0110.4081/monaldi.2023.2793Unveiling vaccine safety: a narrative review of pharmacovigilance in India's COVID-19 vaccinationMegha Hegde0Saurav Raj1Dhananjay Tikadar2Sanatkumar B Nyamagoud3Department of Pharmacy Practice, KLE College of Pharmacy, Hubli, KarnatakaDepartment of Pharmacy Practice, KLE College of Pharmacy, Hubli, KarnatakaDepartment of Pharmacy Practice, KLE College of Pharmacy, Hubli, KarnatakaDepartment of Pharmacy Practice, KLE College of Pharmacy, Hubli, Karnataka In India, a robust vaccine pharmacovigilance system is essential to the effective implementation of COVID-19 immunization programs, ensuring the safety and efficacy of the administered vaccines. The National Expert Group on Vaccine Administration for COVID-19 and the Pharmacovigilance Programme of India have played vital roles in monitoring and analyzing adverse events following immunization (AEFI). These tools have made it easier to gather, assess, and report information about different adverse drug reactions connected to COVID-19 vaccines. However, there are several issues with India's vaccination pharmacovigilance, including underreporting and sluggish data gathering. To improve the efficiency of the pharmacovigilance system, it is crucial to address these issues and encourage active reporting by healthcare professionals and the general public. This insightful review article serves as a critical resource for shedding light on India's vaccine pharmacovigilance efforts throughout the COVID-19 vaccination drive. It also elucidates how these efforts are pivotal in bolstering public confidence in vaccines. The comprehensive coverage of reported AEFI not only showcases the commitment to vaccine safety but also helps healthcare professionals and policymakers make informed decisions to enhance the overall vaccination program. https://www.monaldi-archives.org/index.php/macd/article/view/2793COVID-19AEFIPvPIADRvaccinepandemic |
| spellingShingle | Megha Hegde Saurav Raj Dhananjay Tikadar Sanatkumar B Nyamagoud Unveiling vaccine safety: a narrative review of pharmacovigilance in India's COVID-19 vaccination Monaldi Archives for Chest Disease COVID-19 AEFI PvPI ADR vaccine pandemic |
| title | Unveiling vaccine safety: a narrative review of pharmacovigilance in India's COVID-19 vaccination |
| title_full | Unveiling vaccine safety: a narrative review of pharmacovigilance in India's COVID-19 vaccination |
| title_fullStr | Unveiling vaccine safety: a narrative review of pharmacovigilance in India's COVID-19 vaccination |
| title_full_unstemmed | Unveiling vaccine safety: a narrative review of pharmacovigilance in India's COVID-19 vaccination |
| title_short | Unveiling vaccine safety: a narrative review of pharmacovigilance in India's COVID-19 vaccination |
| title_sort | unveiling vaccine safety a narrative review of pharmacovigilance in india s covid 19 vaccination |
| topic | COVID-19 AEFI PvPI ADR vaccine pandemic |
| url | https://www.monaldi-archives.org/index.php/macd/article/view/2793 |
| work_keys_str_mv | AT meghahegde unveilingvaccinesafetyanarrativereviewofpharmacovigilanceinindiascovid19vaccination AT sauravraj unveilingvaccinesafetyanarrativereviewofpharmacovigilanceinindiascovid19vaccination AT dhananjaytikadar unveilingvaccinesafetyanarrativereviewofpharmacovigilanceinindiascovid19vaccination AT sanatkumarbnyamagoud unveilingvaccinesafetyanarrativereviewofpharmacovigilanceinindiascovid19vaccination |